Aging and proinflammatory cytokines

Aging is associated with increased inflammatory activity reflected by increased circulating levels of TNF-&agr;, IL-6, cytokine antagonists and acute phase proteins in vivo. Epidemiologic studies suggest that chronic low-grade inflammation in aging promotes an atherogenic profile and is related to age-associated disorders (eg, Alzheimer disease, atherosclerosis, type 2 diabetes, etc.) and enhanced mortality risk. Accordingly, a dysregulated production of inflammatory cytokines has an important role in the process of aging. Studies of age-related differences in the production of proinflammatory cytokines in response to acute stimulations in vitro have yielded inconsistent results. However, in vivo infectious models show delayed termination of inflammatory activity and a prolonged fever response in elderly humans, suggesting that the acute phase response is altered in aging. However, a causal relation between the acute phase response and the increased mortality because of bacterial infections in older patients remains to be demonstrated.

[1]  R. Pacifici.  Aging and Cytokine Production , 1999, Calcified Tissue International.

[2]  L. Mion,et al.  Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. , 1996, Age and ageing.

[3]  H J Cohen,et al.  The association of plasma IL-6 levels with functional disability in community-dwelling elderly. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  A. Rudd,et al.  Interleukin-1 production by human monocytes in ageing and disease. , 1989, Age and Ageing.

[5]  B. Pedersen,et al.  Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. , 1999, The Journal of infectious diseases.

[6]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[7]  L. Mao,et al.  Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. , 1996, Journal of immunology.

[8]  N. Binkley,et al.  Elevated Plasma Levels of Interleukin‐6 in Postmenopausal Women Do Not Correlate with Bone Density , 1995, Journal of the American Geriatrics Society.

[9]  M. Schroll,et al.  TNF-alpha, leptin, and lymphocyte function in human aging. , 2000, Life sciences.

[10]  Haimin Xu,et al.  Increase of plasma IL-6 concentration with age in healthy subjects. , 1992, Life sciences.

[11]  M. Schroll,et al.  Ageing, tumour necrosis factor‐alpha (TNF‐α) and atherosclerosis , 2000, Clinical and experimental immunology.

[12]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[13]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[14]  B. Pedersen,et al.  Ageing Is Associated with a Prolonged Fever Response in Human Endotoxemia , 2001, Clinical Diagnostic Laboratory Immunology.

[15]  J. M. Lipton,et al.  Cytokine antagonists in aged subjects and their relation with cellular immunity. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  R. Dobbs,et al.  Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .

[17]  J. Born,et al.  Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep , 1995, Mechanisms of Ageing and Development.

[18]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[19]  B. Pedersen,et al.  A high plasma concentration of TNF-alpha is associated with dementia in centenarians. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  M. Vijaya Lakshmi,et al.  Age-related changes in cerebrospinal fluid protein concentrations , 1991, Journal of the Neurological Sciences.

[21]  Tetsuya Matsumoto,et al.  Lipopolysaccharide-induced lethality and cytokine production in aged mice , 1996, Infection and immunity.

[22]  Pedersen,et al.  Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans , 1999, Clinical and experimental immunology.

[23]  J. Ramirez,et al.  Community-Acquired Pneumonia in the Elderly: Association of Mortality With Lack of Fever and Leukocytosis , 1997, Southern medical journal.

[24]  P. Peterson,et al.  Infections in the elderly. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  C. Feighery,et al.  Quantitative intracellular cytokine measurement: age‐related changes in proinflammatory cytokine production , 1998, Clinical and experimental immunology.

[26]  I. Blasko,et al.  An imbalance between pro- and anti-inflammatory cytokines, a characteristic feature of old age. , 2000, Cytokine.

[27]  H. Chang,et al.  The relationship of aging to endotoxin shock and to production of TNF-alpha. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[28]  D. Ingram,et al.  Aged Mice Exhibit Greater Mortality Concomitant to Increased Brain and Plasma TNF-α Levels following Intracerebroventricular Injection of Lipopolysaccharide , 2000, Gerontology.

[29]  D. Schlossberg,et al.  Streptococcus pneumoniae bacteremia in a community hospital. , 1998, Chest.

[30]  P. Knopf,et al.  Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.

[31]  C. Franceschi,et al.  Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.

[32]  A. Suzumura,et al.  Increased Soluble Tumor Necrosis Factor Receptor Levels in the Serum of Elderly People , 2000, Gerontology.

[33]  Richard A. Miller.  The Aging Immune System: Primer and Prospectus , 1996, Science.

[34]  T. Makinodan.  Role of the immune system in aging. , 1980, Advances in experimental medicine and biology.

[35]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[36]  T. Horie,et al.  Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. , 1996, Clinical and experimental immunology.

[37]  J. McLachlan,et al.  Antitumoral properties of aged human monocytes. , 1995, Journal of immunology.

[38]  D. Mari,et al.  Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  P. Wilson,et al.  Monocyte cytokine production in an elderly population: effect of age and inflammation. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  J. Henrichsen,et al.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94 , 1996, Epidemiology and Infection.

[41]  J. Myśliwska,et al.  The upregulation of TNFα production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life , 1999, Mechanisms of Ageing and Development.

[42]  J. Schölmerich,et al.  Cytokines and hormones as possible links between endocrinosenescence and immunosenescence , 2000, Journal of Neuroimmunology.

[43]  S. Arkins,et al.  Interferon‐γ‐induced priming for secretion of superoxide anion and tumor necrosis factor‐α declines in macrophages from aged rats , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.